ReviewJournal of clinical medicine2016
Bronchiectasis in the Last Five Years: New Developments.
Review in Journal of clinical medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.
- Efficacy and safety of macrolides in the treatment of children with bronchiectasis: a meta-analysis.Pediatric research · 2023Pooled it
- Pooled it
- Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial.The European respiratory journal · 2022Trial
- Effects of periodontal treatment on exacerbation frequency and lung function in patients with chronic periodontitis: study protocol of a 1-year randomized controlled trial.BMC pulmonary medicine · 2017Trial
- Cardiac autonomic function in bronchiectasis and age and gender-matched healthy participants: case-control study.Scientific reports · 2026Article
- An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline.ACS medicinal chemistry letters · 2022Article
- Neutrophil side fluorescence: a new indicator for predicting the severity of patients with bronchiectasis.BMC pulmonary medicine · 2022Article
- Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis.Respiratory research · 2019Article
- Airway clearance services (ACSs) in Australia for adults with chronic lung conditions: scoping review of publicly available web-based information.BMC health services research · 2019Article
- Challenges of diagnosing and managing bronchiectasis in resource-limited settings: a case study.The Pan African medical journal · 2019Article
- Understanding the role of neutrophils in chronic inflammatory airway disease.F1000Research · 2019Review
- Characterization of Microbiota in Bronchiectasis Patients with Different Disease Severities.Journal of clinical medicine · 2018Article
- The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration.Breathe (Sheffield, England) · 2017Review
- Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases.Journal of thoracic disease · 2017Review
- Management of Severe Asthma before Referral to the Severe Asthma Specialist.The journal of allergy and clinical immunology. In practiceReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bronchiectasis, a chronic lung disease characterised by cough and purulent sputum, recurrent infections, and airway damage, is associated with considerable morbidity and mortality. To date, treatment options have been limited to physiotherapy to clear sputum and antibiotics to treat acute infections. Over the last decade, there has been significant progress in understanding the epidemiology, pathophysiology, and microbiology of this disorder. Over the last five years, methods of assessing severity have been developed, the role of macrolide antibiotic therapy in reducing exacerbations cemented, and inhaled antibiotic therapies show promise in the treatment of chronic
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.